Table 1 Patient characteristics
patient | sex | primary | Tx | conditioning | PBSCT/ | death | reason | cytogenetic | number analysed |
|---|---|---|---|---|---|---|---|---|---|
no. | disease | age | BMT | death/day | marker | probes | |||
1 | m | SAA | 10 | n.k. | PBSCT | yes | n.k./+168 | 1 | |
2 | f | AML | 62 | M | PBSCT | no | 6 | ||
3 | f | CML | 51 | C | PBSCT | yes | GvHD/+575 | bcr/abl | 2 |
4 | m | MDS | 37 | M | PBSCT | no | 5 | ||
5 | f | AML | 44 | M | PBSCT | no | 3 | ||
6 | f | ALL | 43 | C | BMT | no | 5 | ||
7 | f | NHL | 39 | M | PBSCT | no | 19 | ||
8 | f | CML | 25 | C | PBSCT | no | 21 | ||
9 | f | AML | 49 | C | PBSCT | no | 3 | ||
10 | f | MM | 57 | C | PBSCT | no | 7 | ||
11 | f | CML | 12 | n.k. | PBSCT | yes | n.k./+110 | 3 | |
12 | f | CML | 43 | n.k. | PBSCT | no | 1 | ||
13 | m | OP | 0 | n.k. | BMT | no | 4 | ||
14 | f | AML | 41 | M | PBSCT | no | trisomy 8 | 17 | |
15 | m | SAA | 49 | M | PBSCT | no | 18 | ||
16 | f | AML | 55 | M | PBSCT | yes | infection/+458 | 3 | |
17 | m | MM | 40 | M | BMT | yes | relapse/+278 | 8 | |
18 | f | AML | 48 | M | PBSCT | yes | relapse/+125 | 3 | |
19 | m | MM | 60 | M | PBSCT | yes | infection/+82 | 2 | |
20 | f | AML | 25 | M | PBSCT | no | 15 | ||
21 | m | ALL | 34 | C | PBSCT | yes | GvHD/+117 | 1 | |
22 | m | CML | 39 | C | PBSCT | no | bcr/abl | 3 | |
23 | f | MDS | 52 | M | PBSCT | no | 15 | ||
24 | f | CML | 1 | n.k. | BMT | no | 3 | ||
25 | f | ALL | 14 | C | PBSCT | yes | n.k./+361 | 2 | |
26 | m | AML | 89 | M | PBSCT | no | 4 | ||
27 | f | AML | 49 | C | PBSCT | no | 14 | ||
28 | f | AML | 48 | M | PBSCT | yes | infection/+144 | 2 | |
29 | m | CML | 49 | C | PBSCT | yes | GvHD/+833 | bcr/abl | 16 |
30 | m | AML | 58 | M | PBSCT | no | 8 | ||
31 | f | CML | 46 | C | PBSCT | no | bcr/abl | 14 | |
32 | m | ALL | 42 | M | PBSCT | no | 11 | ||
33 | m | CML | 46 | C | PBSCT | no | 6 | ||
34 | m | CML | 51 | M | PBSCT | no | bcr/abl | 3 | |
35 | m | AML | 48 | M | PBSCT | yes | relapse/+321 | trisomy 8 | 7 |
36 | m | CML | 43 | M | PBSCT | no | bcr/abl | 22 | |
37 | f | CML | 38 | C | PBSCT | no | bcr/abl | 14 | |
38 | f | AML | 34 | C | PBSCT | no | 21 | ||
39 | f | AML | 53 | M | PBSCT | no | 12 | ||
40 | f | AML | 59 | M | PBSCT | no | 24 | ||
41 | m | CML | 50 | M | PBSCT | yes | relapse/+62 | bcr/abl | 3 |
42 | f | AML | 58 | M | PBSCT | no | 7 | ||
43 | m | AML | 27 | C | PBSCT | yes | relapse/+436 | 7 | |
44 | m | CML | 52 | M | PBSCT | no | bcr/abl | 9 | |
45 | f | CML | 44 | C | PBSCT | no | bcr/abl | 9 | |
46 | m | AML | 46 | C | PBSCT | no | 6 | ||
47 | m | AML | 40 | C | PBSCT | yes | relapse/+484 | 7 | |
48 | m | AML | 50 | M | PBSCT | no | trisomy 8 | 17 | |
49 | f | AML | 50 | M | PBSCT | no | 9 | ||
50 | f | AML | 61 | M | PBSCT | yes | relapse/+286 | 5 | |
51 | m | ALL | 66 | M | PBSCT | yes | relapse/+701 | 3 | |
52 | m | CLL | 58 | M | PBSCT | yes | infection/+599 | 4 | |
53 | m | MM | 49 | M | PBSCT | no | 5 | ||
54 | m | Lym | 45 | C | PBSCT | yes | relapse/+402 | 3 | |
55 | m | SAA | 35 | C | PBSCT | no | 3 | ||
56 | m | CML | 37 | C | PBSCT | no | 2 | ||
57 | f | AML | 20 | C | PBSCT | no | 3 | ||
58 | f | ALL | 26 | C | PBSCT | no | 4 |